Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Murgo

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Reumatismo|July 3, 2007
[Simultaneous ultrasonography and arthroscopy for the study of the joint environment: indications and limits]O De Lucia, E Paresce, A Murgo, et al.
Reumatismo|April 16, 2020
Translation and cross-cultural adaptation into Italian of the self-administered FLARE-RA questionnaire for rheumatoid arthritisN Ughi, T Schioppo, I Scotti, et al.
Clinical and Experimental Rheumatology|February 18, 2014
Levels of chemerin and interleukin 8 in the synovial fluid of patients with inflammatory arthritides and osteoarthritisE Valcamonica, C B Chighizola, D Comi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2000
Homoharringtonine and low-dose cytarabine in the management of late chronic-phase chronic myelogenous leukemiaH M Kantarjian, M Talpaz, T L Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
Phase II trial of bryostatin 1 in patients with relapsed low-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemiaM L Varterasian, R M Mohammad, M S Shurafa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Phase I trial of 72-hour continuous infusion UCN-01 in patients with refractory neoplasmsE A Sausville, S G Arbuck, R Messmann, et al.
British Journal of Cancer|August 30, 2012
Human responses against HER-2-positive cancer cells in human immune system-engrafted miceC De Giovanni, G Nicoletti, L Landuzzi, et al.
Human Gene Therapy|February 14, 2009
A multi-DNA preventive vaccine for p53/Neu-driven cancer syndromeC De Giovanni, G Nicoletti, A Palladini, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|July 9, 2013
[Effects of dose of erythropoiesis stimulating agents on cardiovascular outcomes, quality of life and costs of haemodialysis. the clinical evaluation of the DOSe of erythropoietins (C.E. DOSE) Trial]V Saglimbene, D D'Alonzo, M Ruospo, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Reumatismo|July 3, 2007
[Simultaneous ultrasonography and arthroscopy for the study of the joint environment: indications and limits]O De Lucia, E Paresce, A Murgo, et al.
Reumatismo|April 16, 2020
Translation and cross-cultural adaptation into Italian of the self-administered FLARE-RA questionnaire for rheumatoid arthritisN Ughi, T Schioppo, I Scotti, et al.
Clinical and Experimental Rheumatology|February 18, 2014
Levels of chemerin and interleukin 8 in the synovial fluid of patients with inflammatory arthritides and osteoarthritisE Valcamonica, C B Chighizola, D Comi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2000
Homoharringtonine and low-dose cytarabine in the management of late chronic-phase chronic myelogenous leukemiaH M Kantarjian, M Talpaz, T L Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
Phase II trial of bryostatin 1 in patients with relapsed low-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemiaM L Varterasian, R M Mohammad, M S Shurafa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Phase I trial of 72-hour continuous infusion UCN-01 in patients with refractory neoplasmsE A Sausville, S G Arbuck, R Messmann, et al.
British Journal of Cancer|August 30, 2012
Human responses against HER-2-positive cancer cells in human immune system-engrafted miceC De Giovanni, G Nicoletti, L Landuzzi, et al.
Human Gene Therapy|February 14, 2009
A multi-DNA preventive vaccine for p53/Neu-driven cancer syndromeC De Giovanni, G Nicoletti, A Palladini, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|July 9, 2013
[Effects of dose of erythropoiesis stimulating agents on cardiovascular outcomes, quality of life and costs of haemodialysis. the clinical evaluation of the DOSe of erythropoietins (C.E. DOSE) Trial]V Saglimbene, D D'Alonzo, M Ruospo, et al.
Pageof 2